General
- Updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards, including standards for pediatric oncology. Neuss MN, Gilmore TR, Belderson KM. 2016 J Oncol Pract. 2016;12(12):1262-1271.
- Understanding effective delivery of patient and family education in pediatric oncology. A systematic review from the Children’s Oncology Group. Rodgers CC, Laing CM, Herring RA, et al. J Pediatr Oncol Nurs. 2016;33(6):432-446.
- National Comprehensive Cancer Network
Acute Lymphoblastic Leukemia
- Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. Brown P, Inaba H, Annesley C, et al. J Natl Compr Canc Netw. 2020;18(1):81-112.
Acute Myeloid Leukemia
- Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012. Rasche M, Zimmermann M, Borschel L, et al. 2018;32:2167-2177.
- Pediatric acute myeloid leukemia: updates on biology, risk stratification, and therapy. Current Opin Pediatr. 2020 Feb 32(1):57-66
- How I treat pediatric acute myeloid leukemia. Blood 2021 Sep 23;138(12):1009-18
Central Nervous System Malignancies
- Childhood brain tumors: current management, biological insights, and future directions. J Neurosurg Pediatr. 2019 Mar 1;23(3):261-73
- Brain Tumors in Children. N Engl J Med 2022; 386:1922-1931
Hodgkin’s Lymphoma
- Pediatric Hodgkin Lymphoma, Version 3.2021. J Natl Compr Canc Netw 2021 June 30;19(6):733-54
Immunotherapy/CART-T
- Immunotherapies for pediatric cancer: Current landscape and future perspectives. Hutzen B, Paudel SN, Kararoudi MN, Cassady KA, Lee DA, Cripe TP. Cancer Metastasis Rev. 2019;38(4):573-594.
- Utilization of CAR T Cell therapy in pediatric patients. Szenes V, Curran KJ. Semin Oncol Nurs. 2019;35(5):150929.
Neuroblastoma
- Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and Future. JCO Clin Cancer Inform 2020 Oct 4;895-905
- Neuroblastoma. Pedatr Blood Cancer 2021 May;68 Supp 2:e28473
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma. NEJM 2010 363;14:1324-34.
Non-hodgkin Lymphoma
- Childhood, adolescent and young adult non-Hodgkin lymphoma: current perspectives. Br J Haematol 2019 Jun;185(6):1021-42.
Osteosarcoma/Ewing Sarcoma
- Pediatric malignant bone tumors: A review and update on current challenges, and emerging drug targets. Jackson TM, Bittman M, Granowetter L. Curr Probl Pediatr Adolesc Health Care. 2016;46(7):213-228.
- Osteosarcoma. Pediatr Blood Cancer 2021 May 68 Supp2:e28352
- Bone Tumors in Adolescents and Young Adults. Curr Treat Options in Onc. 2008;9:67-80
Palliative Care
- Palliative care initiation in pediatric oncology patients: A systematic review. Cancer Med. 2019 Jan;8(1) 3-12
- Pediatric Palliative Care in Oncology. JCO. 2020 Mar 20;38(9):954-962
- Pediatric palliative care in oncology. Snaman J, McCarthy S, Weiner L, Wolfe J. J Clin Oncol. 2020;38(9):954-962.
Pharmacogenomics
- Pharmacogenomics in pediatric oncology: Review of gene-drug associations for clinical use. Mlakar V, Huezo-Diaz Curtis P, Uppugunduri CRS, Krajinovic M, Ansari M. Int J Mol Sci. 2016;17(9):1502.
- Pediatric oncology enters an era of precision medicine. Seibel NL, Janeway K, Allen CE, et al. Curr Probl Cancer. 2017;41(3):194-200.
Retinoblastoma
- Retinoblastoma. Pediatr Clin N Amer 2015;62:201-23
Rhabdomyosarcoma
- Consensus and controversies regarding the treatment of rhabdomyosarcoma. Pediatr Blood Cancer 2018;65:e26809
- Recent advances in understanding and managing pediatric rhabdomyosarcoma. F1000Res. 2020 Jul 8;9
Supportive Care
- Tumor Lysis Syndrome
-
- The Tumor Lysis Syndrome. Howard SC, Jones DP, Pui C. N Engl J Med. 2011. 364:1844-1854.
- Guidelines for the management of pediatric and adult tumor lysis syndrome: An evidence-based review. Coiffier B, Atlman A, Pui C, Younes A, Cairo M. J Clin Oncol. 2008;26(16):2767-2778.
- Recommendations for the evaluation and prophylaxis of tumor lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br J Haematol. 2010 May;149(4):578-86
- Febrile Neutropenia
-
- Guidelines for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update. Lehrnbecher T, Robinson P, Fisher B, et al. J Clin Oncol. 2017;35(18):2082-2094.
- Chemotherapy-induced nausea and vomiting
-
- 2016 Updated MASCC/ESMO consensus recommendations: prevention of acute chemotherapy-induced nausea and vomiting in children. Dupuis LL, Sung L, Molassiotis, et al. Supprt Care Cancer. 2017 Jan;25(1):323-331.
- Guideline for the prevention of acute nausea and vomiting due to antineoplastic medication in pediatric cancer patients. Pediatr Blood Cancer. 2013 Jul;60(7):1073-82.
- Mucositis
-
- The management of pediatric oncology inpatients with oral mucositis. Hurrell L, Burgoyne L, Logan R, Revesz T, Gue S. J Pediatr Hematol Oncol. 2019;41(8):e510-e516.
- Guideline for the prevention of oral and oropharyngeal mucositis in children treatment for cancer or undergoing haematopoietic stem cell transplantation. Sung L, Robinson P, Treister N, et al. BMJ Support Palliat Care. 2017;7:7-17.
Wilm's Tumor
- Wilms tumor. Adv Pediatr 2012;59(1):247-67
- Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration. JCO 2015:33(27):2999-3008